NCT05155189 2026-01-21A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular CarcinomaZhejiang UniversityPhase 1 Recruiting72 enrolled
NCT04696055 2025-05-13Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint InhibitorsBayerPhase 2 Completed95 enrolled 14 charts